First Light Asset Management »

Madrigal Pharmaceuticals shares owned by First Light Asset Management

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $39M 67k 582.34
2025-09-30 $5.3M 12k 458.66

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Neogenomics Common Stocks (NEO)
Si-bone Common Stocks (SIBN)
Palvella Therapeutics Common Stocks (PVLA)
Centessa Pharmaceuticals Common Stocks (CNTA)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Atricure Common Stocks (ATRC)
Vera Therapeutics Common Stocks (VERA)
Disc Medicine Common Stocks (IRON)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Edgewise Therapeutics Common Stocks (EWTX)
Madrigal Pharmaceuticals Common Stocks (MDGL)
Twist Bioscience Corporation Common Stocks (TWST)
Simulations Plus Common Stocks (SLP)
Rhythm Pharmaceuticals Common Stocks (RYTM)

View all positions for First Light Asset Management

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Rtw Investments
Henderson Group
Vanguard Group
venBio Select Advisor
Paulson & Co
BlackRock
State Street Corporation
Geode Capital Management
Wellington Management Company
FMR
Invesco
William Blair Investment Management
Goldman Sachs Group
Susquehanna International

View all funds holding Madrigal Pharmaceuticals